PWA
TMO icon

Physician Wealth Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Physician Wealth Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$275K Sell
548
-27
-5% -$13K 0.03% 172
2026
Q1 		$283K Hold
575
– – 0.04% 159
2025
Q4 		$333K Sell
575
-67
-10% -$37.9K 0.05% 132
2025
Q3 		$311K Buy
642
+95
+17% +$44.2K 0.04% 137
2025
Q2 		$222K Sell
547
-44
-7% -$18.4K 0.03% 169
2025
Q1 		$294K Sell
591
-25
-4% -$13.5K 0.05% 139
2024
Q4 		$320K Sell
616
-29
-4% -$15.9K 0.05% 133
2024
Q3 		$387K Buy
645
+49
+8% +$29K 0.07% 109
2024
Q2 		$331K Sell
596
-11
-2% -$6.3K 0.06% 118
2024
Q1 		$337K Buy
607
+20
+3% +$11.2K 0.07% 117
2023
Q4 		$325K Buy
587
+17
+3% +$8.23K 0.07% 115
2023
Q3 		$283K Buy
570
+24
+4% +$12.8K 0.07% 110
2023
Q2 		$283K Buy
546
+45
+9% +$24.3K 0.07% 116
2023
Q1 		$291K Sell
501
-10
-2% -$5.64K 0.08% 112
2022
Q4 		$297K Sell
511
-3
-0.6% -$1.59K 0.08% 112
2022
Q3 		$281K Hold
514
– – 0.09% 113
2022
Q2 		$303K Sell
514
-25
-5% -$13.8K 0.09% 111
2022
Q1 		$303K Sell
539
-50
-8% -$28.7K 0.08% 120
2021
Q4 		$358K Sell
589
-11
-2% -$6.87K 0.09% 110
2021
Q3 		$349K Sell
600
-2
-0.3% -$1.1K 0.1% 106
2021
Q2 		$316K Hold
602
– – 0.09% 113
2021
Q1 		$280K Hold
602
– – 0.09% 116
2020
Q4 		$294K Sell
602
-2
-0.3% -$938 0.1% 108
2020
Q3 		$290K Sell
604
-40
-6% -$16.5K 0.12% 103
2020
Q2 		$264K Sell
644
-58
-8% -$19.4K 0.11% 109
2020
Q1 		$236K Buy
+702
New +$221K 0.12% 95

Other funds holding TMO

Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return

Physician Wealth Advisors's TMO Position: Q2 2026 in Review

Physician Wealth Advisors reduced its Thermo Fisher Scientific (TMO) stake by 4.7% in Q2 2026, selling an estimated $13K and leaving 548 shares worth $275K. The position accounts for 0.03% of the portfolio, ranked #172.

Physician Wealth Advisors first reported a position in TMO in Q1 2020 and has held it in 26 quarters since. The position peaked at $387K in Q3 2024. 1,172 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Physician Wealth Advisors held 548 shares of Thermo Fisher Scientific worth $275K as of Q2 2026.
  • Physician Wealth Advisors sold 27 Thermo Fisher Scientific shares in Q2 2026, an estimated $13K.
  • Thermo Fisher Scientific made up 0.03% of Physician Wealth Advisors's portfolio in Q2 2026, its #172 holding.
  • Physician Wealth Advisors first reported a position in Thermo Fisher Scientific in Q1 2020 and has held it in 26 quarters since.
  • Physician Wealth Advisors's Thermo Fisher Scientific position peaked at $387K in Q3 2024.
  • 1,172 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.